In the news
View the latest updates from the 59 North team and our clients below:
16
Sep
2026
European Biotechnology: Northway opens €61M Vilnius plant built for personalized medicine
15
Sep
2026
In Vivo: How Racura And Cereno Are Repurposing Drugs That Pharma Threw Away
11
Sep
2026
Labiotech: NLS Days 2026 – what’s dealmaking like in the Nordics?
03
Sep
2026
BioXconomy: From private promise to public potential, HaemaLogiX’s journey to market
02
Sep
2026
Business Weekly: Foventa Therapeutics bids for Series A cash under its new brand
01
Sep
2026
Drug Discovery World: Why G‑quadruplex biology is back and what it means for MYC‑driven cancers
20
Aug
2026
Drug Target Review: Why researchers are revisiting bisantrene decades after it was abandoned
07
Aug
2026
MedNous: Targeting one-carbon metabolism in cancer
20
Jul
2026
Clinical Leader: Unlocking Gentler, Cost-Efficient TIL Therapy For Cold Tumors
25
Jun
2026
Drug Discovery News: Reviving a forgotten cancer therapy
23
Jun
2026
Clinical Leader: Why Building Long-Term Value And Making Clinical Progress Are Inextricable
17
Jun
2026
BioCentury: NanoPhoria – Delivering Inhalable Biologics to the Heart
12
Jun
2026
Drug Discovery World: Redefining targeted immunotherapy in multiple myeloma through antigen innovation
11
Jun
2026
Clinical Leader: Designing Trials For Disease Modification: Cereno Scientific’s Approach To Pulmonary Arterial Hypertension
10
Jun
2026
Drug Discovery News: FDA’s drug repurposing initiative signals renewed focus
05
Jun
2026
Fierce Biotech: Affibody gets izokibep ‘back on track’ while seeking ‘new home’ after drug’s Acelyrin rejection
01
Jun
2026
In Vivo: The Nighttime Evidence Gap – How Passive Monitoring Could Reshape Trial Endpoints
26
May
2026
Biospace: 4 troubled targets that have thwarted biopharma
26
May
2026
ICT: Beyond the Clinic – Continuous Symptom Monitoring as the New Gold Standard
22
May
2026
BioPitch: Why One-carbon’s Ana Slipicevic Puts Data Before the Pitch
15
May
2026
GEN: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative
15
May
2026
Scrip: With Selective Targeting, HaemaLogiX Eyes Crowded Multiple Myeloma Space
13
May
2026
Drug Discovery World: A novel approach to HER2-targeted radiotherapy
13
May
2026
Labiotech: TIL therapies – the impact on cancer research
30
Apr
2026
Clinical Trial Vanguard: The Disease-Modification Bet in Pulmonary Arterial Hypertension
30
Apr
2026
Drug Development & Delivery: Affibody Molecules; A Versatile Approach to Radiopharma
28
Apr
2026
Dicot Pharma intends to carry out an 80% already secured rights issue of SEK 210 million
22
Apr
2026
CuraCell Strengthens Board of Directors with Appointment of Thomas Jaecklin and Martin Forster
21
Apr
2026
Mergermarket: CuraCell plans EUR 25m round to fund cancer cell therapy
15
Apr
2026
In Vivo: How An Italian Ocular AAV Innovator Is Bucking The Trend In Gene Therapy
13
Apr
2026
Pink Sheet: Regulatory Alignment Helps Cereno Chart Faster, Cheaper Route For CS014
13
Apr
2026
AgTech Navigator: BetterSeeds and Caszyme target tissue culture bottleneck with viral delivery of ultra‑compact CRISPR tools
07
Apr
2026
BioWorld: One-carbon has new approach to starving tumors of nucleotides
One-carbon CEO Ana Slipicevic sat down with Anette Briendl of BioWorld at the recent BIO Europe Spring conference to discuss the company's first-in-class inhibitor of MTHFD1/...